{
    "P001": {
        "Patient ID": "P001",
        "Age": 32,
        "Sex": "Male",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 71,
        "ALK Fusion": "Positive",
        "Location": "Perth, WA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 19,
        "Best Response": "CR",
        "QoL Baseline": 78,
        "QoL Current": 86,
        "Adverse Events Count": 4,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P002": {
        "Patient ID": "P002",
        "Age": 41,
        "Sex": "Male",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 2,
        "ALK Fusion": "Negative",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-50",
        "Best Response": "PR",
        "QoL Baseline": 60,
        "QoL Current": 78,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P003": {
        "Patient ID": "P003",
        "Age": 47,
        "Sex": "Female",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 37,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-45",
        "Best Response": "PD",
        "QoL Baseline": 92,
        "QoL Current": 73,
        "Adverse Events Count": 1,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P004": {
        "Patient ID": "P004",
        "Age": 75,
        "Sex": "Other",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 21,
        "ALK Fusion": "Positive",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-13",
        "Best Response": "CR",
        "QoL Baseline": 60,
        "QoL Current": 72,
        "Adverse Events Count": 4,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P005": {
        "Patient ID": "P005",
        "Age": 66,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 90,
        "ALK Fusion": "Negative",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 37,
        "Best Response": "CR",
        "QoL Baseline": 83,
        "QoL Current": 87,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "None"
    },
    "P006": {
        "Patient ID": "P006",
        "Age": 77,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 79,
        "ALK Fusion": "Positive",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 1,
        "Best Response": "SD",
        "QoL Baseline": 81,
        "QoL Current": 88,
        "Adverse Events Count": 5,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P007": {
        "Patient ID": "P007",
        "Age": 68,
        "Sex": "Female",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 6,
        "ALK Fusion": "Negative",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 45,
        "Best Response": "SD",
        "QoL Baseline": 86,
        "QoL Current": 68,
        "Adverse Events Count": 4,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P008": {
        "Patient ID": "P008",
        "Age": 35,
        "Sex": "Male",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 3,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-30",
        "Best Response": "PD",
        "QoL Baseline": 48,
        "QoL Current": 66,
        "Adverse Events Count": 0,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P009": {
        "Patient ID": "P009",
        "Age": 70,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 1,
        "ALK Fusion": "Positive",
        "Location": "Perth, WA",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 48,
        "Best Response": "SD",
        "QoL Baseline": 53,
        "QoL Current": 41,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P010": {
        "Patient ID": "P010",
        "Age": 61,
        "Sex": "Male",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 7,
        "ALK Fusion": "Negative",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-25",
        "Best Response": "PR",
        "QoL Baseline": 67,
        "QoL Current": 53,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P011": {
        "Patient ID": "P011",
        "Age": 53,
        "Sex": "Other",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 49,
        "ALK Fusion": "Positive",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-11",
        "Best Response": "PR",
        "QoL Baseline": 53,
        "QoL Current": 49,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P012": {
        "Patient ID": "P012",
        "Age": 71,
        "Sex": "Male",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 3,
        "ALK Fusion": "Positive",
        "Location": "Perth, WA",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-29",
        "Best Response": "SD",
        "QoL Baseline": 41,
        "QoL Current": 26,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P013": {
        "Patient ID": "P013",
        "Age": 61,
        "Sex": "Other",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 33,
        "ALK Fusion": "Negative",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-19",
        "Best Response": "PR",
        "QoL Baseline": 68,
        "QoL Current": 65,
        "Adverse Events Count": 1,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P014": {
        "Patient ID": "P014",
        "Age": 65,
        "Sex": "Male",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 14,
        "ALK Fusion": "Positive",
        "Location": "Perth, WA",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-42",
        "Best Response": "CR",
        "QoL Baseline": 75,
        "QoL Current": 68,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "Missed Visit"
    },
    "P015": {
        "Patient ID": "P015",
        "Age": 70,
        "Sex": "Other",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 23,
        "ALK Fusion": "Negative",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-26",
        "Best Response": "CR",
        "QoL Baseline": 62,
        "QoL Current": 81,
        "Adverse Events Count": 1,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P016": {
        "Patient ID": "P016",
        "Age": 46,
        "Sex": "Female",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 14,
        "ALK Fusion": "Negative",
        "Location": "Perth, WA",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-37",
        "Best Response": "PR",
        "QoL Baseline": 64,
        "QoL Current": 84,
        "Adverse Events Count": 4,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P017": {
        "Patient ID": "P017",
        "Age": 26,
        "Sex": "Female",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 87,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 20,
        "Best Response": "CR",
        "QoL Baseline": 40,
        "QoL Current": 44,
        "Adverse Events Count": 0,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P018": {
        "Patient ID": "P018",
        "Age": 80,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 10,
        "ALK Fusion": "Negative",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-29",
        "Best Response": "PD",
        "QoL Baseline": 83,
        "QoL Current": 70,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P019": {
        "Patient ID": "P019",
        "Age": 52,
        "Sex": "Female",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 34,
        "ALK Fusion": "Positive",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-43",
        "Best Response": "CR",
        "QoL Baseline": 56,
        "QoL Current": 43,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P020": {
        "Patient ID": "P020",
        "Age": 58,
        "Sex": "Other",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 27,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-42",
        "Best Response": "PR",
        "QoL Baseline": 44,
        "QoL Current": 62,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "Missed Visit"
    },
    "P021": {
        "Patient ID": "P021",
        "Age": 51,
        "Sex": "Other",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 32,
        "ALK Fusion": "Negative",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-10",
        "Best Response": "PR",
        "QoL Baseline": 47,
        "QoL Current": 38,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P022": {
        "Patient ID": "P022",
        "Age": 61,
        "Sex": "Female",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 85,
        "ALK Fusion": "Positive",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-38",
        "Best Response": "CR",
        "QoL Baseline": 63,
        "QoL Current": 79,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P023": {
        "Patient ID": "P023",
        "Age": 64,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 77,
        "ALK Fusion": "Positive",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 28,
        "Best Response": "CR",
        "QoL Baseline": 74,
        "QoL Current": 54,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P024": {
        "Patient ID": "P024",
        "Age": 31,
        "Sex": "Male",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 26,
        "ALK Fusion": "Negative",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-24",
        "Best Response": "SD",
        "QoL Baseline": 40,
        "QoL Current": 24,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P025": {
        "Patient ID": "P025",
        "Age": 59,
        "Sex": "Female",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 76,
        "ALK Fusion": "Negative",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-17",
        "Best Response": "PR",
        "QoL Baseline": 54,
        "QoL Current": 48,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Missed Visit"
    },
    "P026": {
        "Patient ID": "P026",
        "Age": 21,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 93,
        "ALK Fusion": "Positive",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-79",
        "Best Response": "PR",
        "QoL Baseline": 71,
        "QoL Current": 72,
        "Adverse Events Count": 4,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P027": {
        "Patient ID": "P027",
        "Age": 32,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 42,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-47",
        "Best Response": "PR",
        "QoL Baseline": 62,
        "QoL Current": 80,
        "Adverse Events Count": 4,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Missed Visit"
    },
    "P028": {
        "Patient ID": "P028",
        "Age": 49,
        "Sex": "Male",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 70,
        "ALK Fusion": "Negative",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-22",
        "Best Response": "PR",
        "QoL Baseline": 75,
        "QoL Current": 67,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P029": {
        "Patient ID": "P029",
        "Age": 45,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 65,
        "ALK Fusion": "Negative",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 48,
        "Best Response": "SD",
        "QoL Baseline": 90,
        "QoL Current": 91,
        "Adverse Events Count": 1,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Missed Visit"
    },
    "P030": {
        "Patient ID": "P030",
        "Age": 45,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 27,
        "ALK Fusion": "Negative",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-17",
        "Best Response": "CR",
        "QoL Baseline": 84,
        "QoL Current": 69,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P031": {
        "Patient ID": "P031",
        "Age": 47,
        "Sex": "Female",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 61,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-50",
        "Best Response": "PR",
        "QoL Baseline": 83,
        "QoL Current": 82,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P032": {
        "Patient ID": "P032",
        "Age": 79,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 96,
        "ALK Fusion": "Negative",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-9",
        "Best Response": "PD",
        "QoL Baseline": 94,
        "QoL Current": 101,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "None"
    },
    "P033": {
        "Patient ID": "P033",
        "Age": 20,
        "Sex": "Female",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 69,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 50,
        "Best Response": "SD",
        "QoL Baseline": 66,
        "QoL Current": 58,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P034": {
        "Patient ID": "P034",
        "Age": 68,
        "Sex": "Other",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 43,
        "ALK Fusion": "Negative",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-8",
        "Best Response": "CR",
        "QoL Baseline": 48,
        "QoL Current": 64,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P035": {
        "Patient ID": "P035",
        "Age": 69,
        "Sex": "Male",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 61,
        "ALK Fusion": "Negative",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 30,
        "Best Response": "PR",
        "QoL Baseline": 93,
        "QoL Current": 104,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P036": {
        "Patient ID": "P036",
        "Age": 56,
        "Sex": "Other",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 1,
        "ALK Fusion": "Positive",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-44",
        "Best Response": "PR",
        "QoL Baseline": 91,
        "QoL Current": 82,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P037": {
        "Patient ID": "P037",
        "Age": 73,
        "Sex": "Other",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 80,
        "ALK Fusion": "Negative",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-30",
        "Best Response": "PD",
        "QoL Baseline": 88,
        "QoL Current": 104,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P038": {
        "Patient ID": "P038",
        "Age": 19,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 91,
        "ALK Fusion": "Negative",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-20",
        "Best Response": "SD",
        "QoL Baseline": 88,
        "QoL Current": 69,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Missed Visit"
    },
    "P039": {
        "Patient ID": "P039",
        "Age": 18,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 18,
        "ALK Fusion": "Positive",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 19,
        "Best Response": "PD",
        "QoL Baseline": 62,
        "QoL Current": 78,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P040": {
        "Patient ID": "P040",
        "Age": 49,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 69,
        "ALK Fusion": "Negative",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-1",
        "Best Response": "PD",
        "QoL Baseline": 41,
        "QoL Current": 46,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P041": {
        "Patient ID": "P041",
        "Age": 73,
        "Sex": "Female",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 16,
        "ALK Fusion": "Negative",
        "Location": "Perth, WA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-34",
        "Best Response": "CR",
        "QoL Baseline": 94,
        "QoL Current": 84,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P042": {
        "Patient ID": "P042",
        "Age": 28,
        "Sex": "Male",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 15,
        "ALK Fusion": "Negative",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-9",
        "Best Response": "SD",
        "QoL Baseline": 63,
        "QoL Current": 47,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P043": {
        "Patient ID": "P043",
        "Age": 20,
        "Sex": "Male",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 19,
        "ALK Fusion": "Negative",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 33,
        "Best Response": "CR",
        "QoL Baseline": 48,
        "QoL Current": 33,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "None"
    },
    "P044": {
        "Patient ID": "P044",
        "Age": 84,
        "Sex": "Other",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 18,
        "ALK Fusion": "Negative",
        "Location": "Perth, WA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-23",
        "Best Response": "PD",
        "QoL Baseline": 75,
        "QoL Current": 73,
        "Adverse Events Count": 3,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P045": {
        "Patient ID": "P045",
        "Age": 69,
        "Sex": "Other",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 32,
        "ALK Fusion": "Positive",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 23,
        "Best Response": "PD",
        "QoL Baseline": 71,
        "QoL Current": 57,
        "Adverse Events Count": 1,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "None"
    },
    "P046": {
        "Patient ID": "P046",
        "Age": 28,
        "Sex": "Other",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 91,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-6",
        "Best Response": "PD",
        "QoL Baseline": 79,
        "QoL Current": 59,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "Missed Visit"
    },
    "P047": {
        "Patient ID": "P047",
        "Age": 48,
        "Sex": "Male",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 93,
        "ALK Fusion": "Negative",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 8,
        "Best Response": "PR",
        "QoL Baseline": 64,
        "QoL Current": 66,
        "Adverse Events Count": 1,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P048": {
        "Patient ID": "P048",
        "Age": 33,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 89,
        "ALK Fusion": "Negative",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-9",
        "Best Response": "PR",
        "QoL Baseline": 74,
        "QoL Current": 60,
        "Adverse Events Count": 0,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P049": {
        "Patient ID": "P049",
        "Age": 18,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 47,
        "ALK Fusion": "Positive",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-23",
        "Best Response": "SD",
        "QoL Baseline": 91,
        "QoL Current": 72,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P050": {
        "Patient ID": "P050",
        "Age": 54,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 31,
        "ALK Fusion": "Positive",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 21,
        "Best Response": "PR",
        "QoL Baseline": 51,
        "QoL Current": 35,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P051": {
        "Patient ID": "P051",
        "Age": 36,
        "Sex": "Male",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 47,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 10,
        "Best Response": "SD",
        "QoL Baseline": 94,
        "QoL Current": 82,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P052": {
        "Patient ID": "P052",
        "Age": 71,
        "Sex": "Female",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 32,
        "ALK Fusion": "Positive",
        "Location": "Perth, WA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 45,
        "Best Response": "PR",
        "QoL Baseline": 59,
        "QoL Current": 62,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P053": {
        "Patient ID": "P053",
        "Age": 53,
        "Sex": "Other",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 37,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-12",
        "Best Response": "CR",
        "QoL Baseline": 50,
        "QoL Current": 37,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P054": {
        "Patient ID": "P054",
        "Age": 42,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 92,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 10,
        "Best Response": "PD",
        "QoL Baseline": 74,
        "QoL Current": 78,
        "Adverse Events Count": 1,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P055": {
        "Patient ID": "P055",
        "Age": 83,
        "Sex": "Female",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 53,
        "ALK Fusion": "Negative",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 37,
        "Best Response": "CR",
        "QoL Baseline": 85,
        "QoL Current": 82,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P056": {
        "Patient ID": "P056",
        "Age": 50,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 67,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 6,
        "Best Response": "SD",
        "QoL Baseline": 55,
        "QoL Current": 75,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Missed Visit"
    },
    "P057": {
        "Patient ID": "P057",
        "Age": 65,
        "Sex": "Other",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 19,
        "ALK Fusion": "Negative",
        "Location": "Perth, WA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-28",
        "Best Response": "CR",
        "QoL Baseline": 53,
        "QoL Current": 53,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P058": {
        "Patient ID": "P058",
        "Age": 65,
        "Sex": "Other",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 75,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 8,
        "Best Response": "CR",
        "QoL Baseline": 56,
        "QoL Current": 68,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Missed Visit"
    },
    "P059": {
        "Patient ID": "P059",
        "Age": 39,
        "Sex": "Male",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 29,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-29",
        "Best Response": "SD",
        "QoL Baseline": 90,
        "QoL Current": 91,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P060": {
        "Patient ID": "P060",
        "Age": 44,
        "Sex": "Female",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 26,
        "ALK Fusion": "Negative",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-70",
        "Best Response": "CR",
        "QoL Baseline": 77,
        "QoL Current": 64,
        "Adverse Events Count": 1,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P061": {
        "Patient ID": "P061",
        "Age": 45,
        "Sex": "Other",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 63,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 33,
        "Best Response": "PD",
        "QoL Baseline": 60,
        "QoL Current": 69,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P062": {
        "Patient ID": "P062",
        "Age": 21,
        "Sex": "Female",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 34,
        "ALK Fusion": "Negative",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-30",
        "Best Response": "SD",
        "QoL Baseline": 44,
        "QoL Current": 42,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P063": {
        "Patient ID": "P063",
        "Age": 47,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 92,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 48,
        "Best Response": "PD",
        "QoL Baseline": 56,
        "QoL Current": 63,
        "Adverse Events Count": 5,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P064": {
        "Patient ID": "P064",
        "Age": 54,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 23,
        "ALK Fusion": "Positive",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-14",
        "Best Response": "PD",
        "QoL Baseline": 92,
        "QoL Current": 77,
        "Adverse Events Count": 4,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P065": {
        "Patient ID": "P065",
        "Age": 77,
        "Sex": "Other",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 96,
        "ALK Fusion": "Positive",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-36",
        "Best Response": "PD",
        "QoL Baseline": 88,
        "QoL Current": 98,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P066": {
        "Patient ID": "P066",
        "Age": 50,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 66,
        "ALK Fusion": "Negative",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-32",
        "Best Response": "PD",
        "QoL Baseline": 60,
        "QoL Current": 71,
        "Adverse Events Count": 1,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "None"
    },
    "P067": {
        "Patient ID": "P067",
        "Age": 71,
        "Sex": "Female",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 57,
        "ALK Fusion": "Negative",
        "Location": "Perth, WA",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 24,
        "Best Response": "PD",
        "QoL Baseline": 64,
        "QoL Current": 74,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Missed Visit"
    },
    "P068": {
        "Patient ID": "P068",
        "Age": 49,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 46,
        "ALK Fusion": "Negative",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-20",
        "Best Response": "PD",
        "QoL Baseline": 79,
        "QoL Current": 82,
        "Adverse Events Count": 5,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P069": {
        "Patient ID": "P069",
        "Age": 44,
        "Sex": "Female",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 1,
        "ALK Fusion": "Negative",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 25,
        "Best Response": "SD",
        "QoL Baseline": 62,
        "QoL Current": 43,
        "Adverse Events Count": 1,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P070": {
        "Patient ID": "P070",
        "Age": 50,
        "Sex": "Female",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 8,
        "ALK Fusion": "Positive",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-17",
        "Best Response": "SD",
        "QoL Baseline": 56,
        "QoL Current": 75,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P071": {
        "Patient ID": "P071",
        "Age": 59,
        "Sex": "Other",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 25,
        "ALK Fusion": "Positive",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 37,
        "Best Response": "SD",
        "QoL Baseline": 93,
        "QoL Current": 111,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P072": {
        "Patient ID": "P072",
        "Age": 41,
        "Sex": "Other",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 12,
        "ALK Fusion": "Negative",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-43",
        "Best Response": "SD",
        "QoL Baseline": 89,
        "QoL Current": 93,
        "Adverse Events Count": 3,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P073": {
        "Patient ID": "P073",
        "Age": 62,
        "Sex": "Other",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 19,
        "ALK Fusion": "Positive",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 29,
        "Best Response": "PR",
        "QoL Baseline": 46,
        "QoL Current": 61,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "None"
    },
    "P074": {
        "Patient ID": "P074",
        "Age": 31,
        "Sex": "Female",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 75,
        "ALK Fusion": "Negative",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-41",
        "Best Response": "PD",
        "QoL Baseline": 47,
        "QoL Current": 42,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Missed Visit"
    },
    "P075": {
        "Patient ID": "P075",
        "Age": 83,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 31,
        "ALK Fusion": "Positive",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-2",
        "Best Response": "SD",
        "QoL Baseline": 62,
        "QoL Current": 56,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P076": {
        "Patient ID": "P076",
        "Age": 75,
        "Sex": "Other",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 62,
        "ALK Fusion": "Positive",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-14",
        "Best Response": "PR",
        "QoL Baseline": 90,
        "QoL Current": 94,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Missed Visit"
    },
    "P077": {
        "Patient ID": "P077",
        "Age": 66,
        "Sex": "Female",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 51,
        "ALK Fusion": "Negative",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 103,
        "Best Response": "SD",
        "QoL Baseline": 61,
        "QoL Current": 62,
        "Adverse Events Count": 1,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P078": {
        "Patient ID": "P078",
        "Age": 71,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 59,
        "ALK Fusion": "Negative",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-13",
        "Best Response": "SD",
        "QoL Baseline": 45,
        "QoL Current": 39,
        "Adverse Events Count": 4,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P079": {
        "Patient ID": "P079",
        "Age": 70,
        "Sex": "Male",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 59,
        "ALK Fusion": "Negative",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 8,
        "Best Response": "SD",
        "QoL Baseline": 72,
        "QoL Current": 59,
        "Adverse Events Count": 3,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Missed Visit"
    },
    "P080": {
        "Patient ID": "P080",
        "Age": 85,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 5,
        "ALK Fusion": "Negative",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 31,
        "Best Response": "PD",
        "QoL Baseline": 83,
        "QoL Current": 67,
        "Adverse Events Count": 4,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P081": {
        "Patient ID": "P081",
        "Age": 64,
        "Sex": "Male",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 98,
        "ALK Fusion": "Positive",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 8,
        "Best Response": "SD",
        "QoL Baseline": 71,
        "QoL Current": 80,
        "Adverse Events Count": 3,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P082": {
        "Patient ID": "P082",
        "Age": 47,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 18,
        "ALK Fusion": "Positive",
        "Location": "Perth, WA",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 6,
        "Best Response": "PR",
        "QoL Baseline": 55,
        "QoL Current": 47,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "Missed Visit"
    },
    "P083": {
        "Patient ID": "P083",
        "Age": 75,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 54,
        "ALK Fusion": "Negative",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 8,
        "Best Response": "CR",
        "QoL Baseline": 58,
        "QoL Current": 65,
        "Adverse Events Count": 1,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P084": {
        "Patient ID": "P084",
        "Age": 79,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 22,
        "ALK Fusion": "Positive",
        "Location": "Adelaide, SA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-21",
        "Best Response": "SD",
        "QoL Baseline": 76,
        "QoL Current": 81,
        "Adverse Events Count": 0,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P085": {
        "Patient ID": "P085",
        "Age": 75,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 0,
        "ALK Fusion": "Positive",
        "Location": "Perth, WA",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-5",
        "Best Response": "PR",
        "QoL Baseline": 51,
        "QoL Current": 31,
        "Adverse Events Count": 1,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P086": {
        "Patient ID": "P086",
        "Age": 18,
        "Sex": "Male",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 15,
        "ALK Fusion": "Negative",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-37",
        "Best Response": "PD",
        "QoL Baseline": 71,
        "QoL Current": 75,
        "Adverse Events Count": 4,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "Missed Visit"
    },
    "P087": {
        "Patient ID": "P087",
        "Age": 39,
        "Sex": "Other",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 92,
        "ALK Fusion": "Positive",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 4,
        "Best Response": "CR",
        "QoL Baseline": 78,
        "QoL Current": 62,
        "Adverse Events Count": 2,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P088": {
        "Patient ID": "P088",
        "Age": 33,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "II",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 50,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 20,
        "Best Response": "SD",
        "QoL Baseline": 51,
        "QoL Current": 56,
        "Adverse Events Count": 4,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P089": {
        "Patient ID": "P089",
        "Age": 64,
        "Sex": "Female",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 93,
        "ALK Fusion": "Negative",
        "Location": "Brisbane, QLD",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 8,
        "Best Response": "PD",
        "QoL Baseline": 61,
        "QoL Current": 69,
        "Adverse Events Count": 5,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P090": {
        "Patient ID": "P090",
        "Age": 33,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 89,
        "ALK Fusion": "Negative",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-39",
        "Best Response": "PD",
        "QoL Baseline": 91,
        "QoL Current": 75,
        "Adverse Events Count": 1,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P091": {
        "Patient ID": "P091",
        "Age": 56,
        "Sex": "Other",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "III",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 99,
        "ALK Fusion": "Negative",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 4,
        "Best Response": "CR",
        "QoL Baseline": 87,
        "QoL Current": 87,
        "Adverse Events Count": 0,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P092": {
        "Patient ID": "P092",
        "Age": 40,
        "Sex": "Other",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 9,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": 21,
        "Best Response": "SD",
        "QoL Baseline": 69,
        "QoL Current": 85,
        "Adverse Events Count": 5,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "Missed Visit"
    },
    "P093": {
        "Patient ID": "P093",
        "Age": 51,
        "Sex": "Female",
        "Cancer Type": "Lymphoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 51,
        "ALK Fusion": "Positive",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-11",
        "Best Response": "SD",
        "QoL Baseline": 44,
        "QoL Current": 59,
        "Adverse Events Count": 1,
        "Severe AE Flag": "No",
        "Secondary Infection": "No",
        "Protocol Deviations": "None"
    },
    "P094": {
        "Patient ID": "P094",
        "Age": 18,
        "Sex": "Other",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 68,
        "ALK Fusion": "Positive",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-2",
        "Best Response": "PD",
        "QoL Baseline": 58,
        "QoL Current": 69,
        "Adverse Events Count": 4,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Sepsis",
        "Protocol Deviations": "None"
    },
    "P095": {
        "Patient ID": "P095",
        "Age": 41,
        "Sex": "Other",
        "Cancer Type": "Melanoma",
        "Cancer Stage": "I",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 79,
        "ALK Fusion": "Positive",
        "Location": "Sydney, NSW",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": "-72",
        "Best Response": "PD",
        "QoL Baseline": 43,
        "QoL Current": 38,
        "Adverse Events Count": 1,
        "Severe AE Flag": "No",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P096": {
        "Patient ID": "P096",
        "Age": 49,
        "Sex": "Other",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "III",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 90,
        "ALK Fusion": "Positive",
        "Location": "Melbourne, VIC",
        "Enrollment Status": "Excluded",
        "Tumor Size Change (%)": 12,
        "Best Response": "SD",
        "QoL Baseline": 88,
        "QoL Current": 95,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - COVID-19",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P097": {
        "Patient ID": "P097",
        "Age": 67,
        "Sex": "Male",
        "Cancer Type": "Non-Small Cell Lung Cancer",
        "Cancer Stage": "II",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 34,
        "ALK Fusion": "Positive",
        "Location": "Auckland, NZ",
        "Enrollment Status": "Enrolled",
        "Tumor Size Change (%)": "-13",
        "Best Response": "SD",
        "QoL Baseline": 63,
        "QoL Current": 54,
        "Adverse Events Count": 3,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "Eligibility Violation"
    },
    "P098": {
        "Patient ID": "P098",
        "Age": 78,
        "Sex": "Male",
        "Cancer Type": "Breast Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Positive",
        "PD-L1 Expression (%)": 50,
        "ALK Fusion": "Negative",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-45",
        "Best Response": "PD",
        "QoL Baseline": 72,
        "QoL Current": 84,
        "Adverse Events Count": 2,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P099": {
        "Patient ID": "P099",
        "Age": 84,
        "Sex": "Other",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "IV",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 64,
        "ALK Fusion": "Negative",
        "Location": "Canberra, ACT",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": "-75",
        "Best Response": "SD",
        "QoL Baseline": 76,
        "QoL Current": 67,
        "Adverse Events Count": 0,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "Yes - Pneumonia",
        "Protocol Deviations": "None"
    },
    "P100": {
        "Patient ID": "P100",
        "Age": 60,
        "Sex": "Other",
        "Cancer Type": "Colon Cancer",
        "Cancer Stage": "I",
        "EGFR Mutation": "Negative",
        "PD-L1 Expression (%)": 43,
        "ALK Fusion": "Negative",
        "Location": "Perth, WA",
        "Enrollment Status": "Screened",
        "Tumor Size Change (%)": 49,
        "Best Response": "PR",
        "QoL Baseline": 79,
        "QoL Current": 68,
        "Adverse Events Count": 4,
        "Severe AE Flag": "Yes",
        "Secondary Infection": "No",
        "Protocol Deviations": "Missed Visit"
    }
}
